Relative to trend US obesity is down about 7 percentage points (~20%) among graduates (the group most likely to be using GLP-1 agonists like Ozempic).
Incredible stuff.
We may have passed peak obesity: ft.com/content/21bd0b
Quote
Rob Wiblin
@robertwiblin
I wonder how long until Ozempic etc start showing up in national stats as rapidly declining obesity and rising life expectancy.
If I were overweight I would walk over hot coals to get a script.
"...people with pre-diabetes taking Zepbound had a 93% lower risk of progressing to
Show more63.7K
Views